Compound ID | 2202
Synonym(s): LCB10-0200
Class: Beta-lactam
Spectrum of activity: | Gram-negative |
Details of activity: | Active against Pseudomonas aeruginosa including beta-lactamase producing strains |
Description: | Synthetic compound; siderophore-cephalosporin conjugate; combination with GT-055 also shows activity against Burkholderia pseudomallei and Yersinia pestis |
Institute where first reported: | LegoChem Biosciences (Daejeon, South Korea) and Geom Therapeutics (San Francisco, CA, USA) |
Year first mentioned: | 2017 |
Highest developmental phase: | Phase 1 (Australia ACTRN12618001980224) |
Development status: | Discontinued |
Reason Dropped: | Unspecified safety reasons (suspected hepatotoxicity) |
Chemical structure(s): | |||||||||||
|
|
External links: | |
PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/145283404 |
Guide to Pharmacology: | GT-1 |
Citations: |
|
Patent: | WO2017055922 |